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 Abstract 
 More than 1,100 diabetes apps are available, but are infrequently used. A systematic 
review identified unsatisfactory diabetes app usability and its clinical effect to lower 
hemoglobin A1c level (0.15% to 1.9%), with variations in interactive app features for real-
time feedback through automatic data analysis, clinician text messages, reminder alerts, or an 
app-initiated phone call. This result identified the need for health behavior theory 
applications to guide diabetes app usability evaluation. This study applied the Self-
Determination Theory on human motivation to select app testing functions and to understand 
adult patient perspectives to use apps. A total of 92 adults with diabetes type 1 or 2 
participated in a randomized crossover trial to test the usability of two top-rated Android 
diabetes apps (mySugr and OnTrack). Multivariable linear regression models assessed the 
effects of patient characteristics (i.e., age, education, and diabetes) and psychological needs 
on user satisfaction and user performance. Psychological needs important for motivation and 
behavioral change were associated with diabetes app usability. Higher user satisfaction was 
observed for participants who reported competence, autonomy, or connectivity with a 
healthcare provider. To enhance motivation to use apps for self-management, clinicians 
should consider addressing the patient’s competence, autonomy, and connectivity. User 
performance was associated with patient characteristics of age, sex, education, and diabetes 
duration because they affect the patient’s ability to use apps efficiently, successfully, and 
accurately. App training and ongoing technical support should be tailored for older adults, 
men, patients with less education, and those with diabetes duration more than 10 years.  
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 Chapter 1: Introduction 
1.1 Background  
Diabetes is a leading chronic disease in the United States that affects 9.4% of the 
American population, an estimated 30.3 million people of all ages, with 25.5% among 
those aged 65 years or older (Centers for Disease Control and Prevention, 2017). Poor 
diabetes management is associated with increased morbidity and mortality with 2.3 times 
higher healthcare expenditures than those without diabetes (Ozieh, Bishu, Dismuke, & 
Egede, 2015). The economic burden for diabetes in the United States exceeded $322 
billion in 2012 (Dall et al., 2014). Patients with diabetes experience more work 
limitations (Tunceli et al., 2005) and sickness episodes (De Backer et al., 2006). They 
leave the work force earlier, a 30% increase compared to those without diabetes 
(Rumball-Smith, Barthold, Nandi, & Heymann, 2014). Using mobile health (mHealth) 
technology, which allows health services and information to be delivered via a patient’s 
mobile device, can facilitate quicker access to information, fill gaps of care, and promote 
adherence to self-management behaviors (Kumar, Nilsen, Pavel, & Srivastava, 2013).  
Smartphones can deliver a diabetes care plan in the form of a software application 
(app). Apps can assist patients in identifying and incorporating healthy behaviors into 
their daily lives (Heinrich, Schaper, & de Vries, 2010). However, the rate of diabetes app 
use is low despite more than 1,100 apps available in the market (Research2Guidance, 
2014). Most health apps did not consistently apply a health behavior theory (Riley et al., 
2011) in their design, which may be important for positive patient experience and long-
term app use. Most diabetes apps have limited functionality because their primary 
functions are data input and output only (Arnhold, Quade, & Kirch, 2014). Examples of 
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 other standard app functions include data analysis, data upload for cloud storage, data 
sharing, alert reminders, and low-carb diet recipes. Additional app functions can make it 
confusing for some users (Arnhold et al., 2014). Screens may have too many icons, which 
may make it difficult for patients to navigate to different screens and read data reports 
(Caburnay et al., 2015; Georgsson & Staggers, 2016a). Poor usability experience leads to 
low app usage. Therefore, it is important to study diabetes app qualities and patients’ 
perspectives of their usability. 
 
1.2 Diabetes App Usability 
 Usability is the extent to which a product can be used by a specific person in a 
specific context to achieve realistic goals of effectiveness, efficiency, and satisfaction as 
defined by the International Organization for Standardization 9241-11 (ISO 9241-11, 
1998). With diabetes apps, usability refers to the interface experience for a particular user 
(e.g., patient, clinician, or caregiver) to use the app with an expectation of good 
satisfaction, reasonable efficiency to save time, and adequate effectiveness that the app 
works successfully and accurately in a desired use context (e.g., tracking and analyzing 
BG and carb intake). Individual patient characteristics can influence usability experience. 
Adequate patient confidence and satisfaction are tied with health behaviors and long-term 
app use (Goldwater, 2014). As such, it is essential to apply health behavior theories to 
understand patient perspective and experience of usability of an app to support patients to 
make behavior changes important in diabetes self-management. 
 
1.3 Health Behavior Theories for mHealth Tools 
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 Four health behavior theories commonly used in mHealth interventions are: 
Social Cognitive Theory (SCT) (Bandura, 2001, 2008), Theory of Planned Behavior 
(Ajzen, 1991), Transtheoretical Model of Behavior Change (Prochaska & Velicer, 1997), 
and Self-Determination Theory (SDT) (Ryan & Deci, 2000). According to SCT, self-
efficacy is the patient’s belief in their ability to control their level of functioning and 
events. (Bandura, 2001). App functions for data input and output may increase self-
efficacy. Patients can visualize data and formulate goals to improve their diabetes control. 
According to the Theory of Planned Behavior, patients expend more effort in performing 
a behavior when they believe they can control that behavior (Ajzen, 1991). A diabetes 
app can improve “perceived behavior control” by setting an alarm schedule for testing 
BG. According to the Transtheoretical Model, patients progress through six stages of 
change when adapting health behavior changes (Prochaska & Velicer, 1997). This theory 
may be applied to apps that tailor feedback educational messages based on the patient’s 
reported stage of change and associated needs. SDT suggests motivation for behavior 
change is increased when patients experience satisfaction of their inherent psychosocial 
needs for competence, autonomy, and relatedness (Ryan & Deci, 2000). Some smoking 
cessation apps applied SDT by including app messages on patient education on smoking 
risk (e.g., lung cancer) to address the need for competence such as gaining knowledge. 
The apps can also provide a menu of smoking cessation aids (e.g., nicotine patch, gum, 
and lozenge) as choice that supports the patient’s autonomy to choose how to quit 
smoking. The apps can target the need for relatedness by providing a link to support 
groups in social media. Few diabetes apps explicitly use health behavior theory in their 
designs. Some apps may have implicit theoretical underpinnings. 
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1.4 Significance 
 Additional research can help identify the relationships between diabetes app 
usability and individual patient characteristics and how this relationship may explain 
patient motivation to use this technology with a health behavior theory. Self-
Determination Theory on motivation can serve as a guiding principle for diabetes app 
design and usability testing. This theory was selected because of it has been used to 
understand patient engagement in diabetes care (Kasser & Ryan, 1999; Koponen, 
Simonsen, Laamanen, & Suominen, 2015; Mohn et al., 2015; Nouwen et al., 2011) and to 
design diabetes research interventions (Hunt, Sanderson, & Ellison, 2014; Johnson, 
2007). Research indicates that motivational support from healthcare providers is critical 
for successful patient self-management (Graffigna, Barello, Bonanomi, & Menichetti, 
2016). Currently, many diabetes apps offer functions that may provide motivational 
support such as helping patients gain competence in diabetes management. These apps 
can analyze BG readings and help patients track how often their BG readings are in 
range. The degree to which patients are satisfied with diabetes apps and their 
effectiveness of motivational support provided is unknown.  
 Testing diabetes app usability and understanding how patient characteristics affect 
usability will fill a critical knowledge gap related to best practices in promoting diabetes 
self-management using mHealth tools. To date, mHealth studies have included diabetes 
apps as part of a communication platform, data sharing, patient portal, web-based 
program, and text messaging interventions (Lyles, Sarkar, & Osborn, 2014; Sutcliffe et 
al., 2011). These studies did not assess how well diabetes apps met patients’ self-
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 management needs, and whether individual patient differences influence usability. 
Applying SDT to guide the usability evaluation of app design can help close this research 
gap. Furthermore, application of health behavior theory can provide the linkages between 
product design, mobile technology adoption, and motivation factors pivotal for patient 
engagement in diabetes self-management. This contribution adds knowledge to mHealth 
science. 
 
1.5 Application of the Self-Determination Theory to Diabetes Apps  
 SDT posits that motivation regulates health behavior. Inner motivation is self-
initiated when one personally endorses the importance of healthy behaviors (Ryan, Deci, 
& Williams, 2008). When patients recognize the personal benefit of using an app, they 
are more motivated to initiate and sustain their use of the app. Diabetes apps need to have 
a user-centered design that can be adjusted to fit individual patient characteristics and 
needs. Likewise, diabetes apps need to address psychosocial needs. Patients have inherent 
needs for competence, autonomy, and relatedness (Ryan & Deci, 2000).  
 Competence refers to patient confidence to manage their diabetes such as keeping 
their BG in target range (Williams, Freedman, & Deci, 1998). An app can address 
competence needs by providing a function that allows patients to analyze their BG levels. 
The analysis reports of BG patterns for each day of the week serve to increase the 
knowledge of diabetes numeracy. An app can help patients understand the BG reading 
numbers and how they were affected by their diet, medication, and physical activity. An 
app can help patients plan which day of the week to target behavior change, for example, 
seeing a higher frequency of elevated BG reading in the weekends due to eating out with 
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 friends in restaurants may help a patient realize the need to change and to choose 
restaurants that offer a diabetic diet.   
 Autonomy means that patients desire empowerment in having a menu of options 
or choices to change their behavior (R. Ryan et al., 2008). Patients are more likely to use 
apps when the apps can personalize a care plan and help to identify areas to improve 
diabetes self-management behaviors. An app can address the need for autonomy by 
providing BG reports and carb intake patterns for each meal. Patients can visualize which 
meal requires better carb control and create an action plan with various choices to 
improve diabetes control in behavior modification for diet, physical activity, medication 
taking, and stress management, among others. 
 Relatedness is “the need to care and be cared for” (Deci & Ryan, 1985). Patients 
are more likely to adopt behaviors promoted by people with whom they are connected 
and trust (R. Ryan et al., 2008). In an mHealth setting, one translation of this is 
“connection with healthcare providers,” as well as with people from their social network 
or caregivers. Apps might address this need by providing communication and data 
sharing support through email functionality.  
 
1.6 Purpose and Specific Aims 
 The overall purpose for this dissertation was to appraise diabetes app usability 
based on the Self-Determination Theory to understand patient perspectives and 
motivation to use diabetes apps. To accomplish this, this study was composed of two 
phases. Phase One was to conduct a systematic review of the research literature on 
diabetes app usability and its clinical effectiveness in improving diabetes outcomes. 
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 Evidence of diabetes app components and patient response to diabetes apps in a clinical 
setting laid the foundation for usability testing design in the second phase. Phase Two 
included a crossover randomized trial of patient testing diabetes apps that used SDT as 
the theoretical underpinnings to select app functions and measurements of psychosocial 
needs related to motivation in diabetes self-management. The specific research aims for 
this phase were to: 
(1) Determine the relationships between patient characteristics (e.g., age, sex, 
race/ethnicity, education, technology use, diabetes history, glycemic status, BG 
monitoring frequency, and motivation) and diabetes app usability.  This study 
hypothesized that, 
A. Patient characteristics will predict user satisfaction with two diabetes apps, 
and  
B. Patient characteristics will predict user performance with two diabetes apps 
measured in time, success, and accuracy rates.  
(2) Determine the relationships between psychosocial needs important for 
motivation (e.g., competence, autonomy, and healthcare provider connectivity) 
and diabetes app usability. This study hypothesized that,  
C. Higher satisfaction of psychosocial needs will be associated with higher user 
satisfaction with diabetes apps. 
 
1.7 Overview  
 In this dissertation, we are exploring the applicability of using a health behavior 
theory in the usability evaluation mHealth tools such as diabetes apps for adult patients 
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 with diabetes. This dissertation is organized into four chapters. Chapter 1 provides 
background information and overview of the research. Chapter 2 describes past and 
present research related to diabetes app usability and its clinical effectiveness in 
improving glycemic control for adult patients with type 2 diabetes. Type 2 diabetes was 
selected as the focus for the review because type 2 diabetes is more prevalent in the 
United States (US) accounting for 90–95% of all diabetes cases (Centers for Disease 
Control and Prevention, 2017). Chapter 3 presents a quantitative study of patients testing 
diabetes app usability guided by the Self-Determination Theory on motivation. A total of 
92 adults with type 1 or type 2 diabetes were recruited to test two top-rated diabetes apps. 
Patient characteristics and behavior needs were examined for their influence in user 
satisfaction and user performance using two diabetes apps for the first time.  
 The final section of this dissertation, Chapter 4, integrates prior research 
evidences of diabetes app usability and new evidence from patient evaluation of diabetes 
apps together to create a summary and a set of recommendations for future research and 
clinical practice implication. This includes revealing key patient characteristics and 
behavior needs critical for user-centered app designs. Chapter 4 also discusses study 
limitations and more importantly the role of health behavior theory in mHealth 
intervention design and implementation.  
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 Synopsis 
Objectives: To assess the usability and clinical effectiveness of diabetes mobile 
applications (diabetes apps) developed for adults with type 2 diabetes.  
Method: A systematic review of the usability and effectiveness of diabetes apps was 
conducted. Searches were performed using MEDLINE, EMBASE, COMPENDEX, and 
IEEE XPLORE for articles published from January 1, 2011, to January 17, 2017. Search 
terms included: diabetes, mobile apps, and mobile health (mHealth).  
Results: The search yielded 723 abstracts of which seven usability studies and ten clinical 
effectiveness studies met the inclusion criteria from 20 publications. Usability, as 
measured by satisfaction ratings from experts and patients, ranged from 38% to 80%. 
Usability problem ratings ranged from moderate to catastrophic. Top usability problems 
are multi-steps task, limited functionality and interaction, and difficult system navigation. 
Clinical effectiveness, measured by reductions in HbA1c, ranged from 0.15% to 1.9%.  
Conclusion: Despite meager satisfaction ratings and major usability problems, there is 
some limited evidence supporting the effectiveness of diabetes apps to improve glycemic 
control for adults with type 2 diabetes. Findings strongly suggest that efforts to improve 
user satisfaction, incorporate established principles of health behavior change, and match 
apps to user characteristics will increase the therapeutic impact of diabetes apps  
  
 11 
 1. Introduction 
Type 2 diabetes (T2D) affects 382 million patients worldwide.  This number is expected 
to increase by 35% globally in the coming years [1].  Poor glycemic control leads to 
complications, such as coronary heart disease or stroke (36.6%) [2]; visual impairment 
(19.1%) [3]; death related to hyperglycemic crisis (12.3% rate per 100,000 diabetic 
population) [4]; and limb amputation (3.3% rate per 1,000 diabetic population) [5].  
Mobile health applications (apps) delivered through smartphones or tablets have the 
potential to help patients manage their diabetes.  In 2014, 90% of Americans owned 
mobile phones, with 64% using smartphones [6].  Research indicates that using a diabetes 
app through a smartphone to track blood glucose (BG) and diet can increase adherence to 
diabetes management and self-monitoring [7].  However, the evidence of diabetes app 
clinical effectiveness is inconclusive.  Small clinical trials have reported reductions in 
hemoglobin A1c (HbA1c) ranging from minimal to 0.49% [8,9] with 0.5% reduction as 
the benchmark for clinically meaningful change [10].  Furthermore, the rate of diabetes 
app usage is low [11].  One reason for their low use could be problems in their usability 
or the ease of using the app. 
Mobile apps are a relatively new technology, so few studies have tested them as a 
clinical intervention.  Some diabetes app usability studies are not routinely published 
because app developers perform usability evaluations internally before releasing the 
product to the market [12].  Furthermore, with limited regulatory oversight, diabetes apps 
do not need to have documentation of effectiveness [13,14]. Current usability literature 
tends to focus on communications platforms, data sharing, patient portal, web-based 
intervention, and text messaging capabilities of diabetes apps [12,15].  When studies 
 12 
 tested clinical effectiveness, diabetes app functions were limited to data upload, 
education access, and text messaging notification [8,14,16].  Clinical effectiveness was 
increased when the app design promoted greater interactivity between patients and 
providers [17].   
This systematic review aims to: (1) to describe the usability evidence specific to 
diabetes apps, and (2) to identify the clinical effectiveness of diabetes app use in T2D.  
Usability is “the extent to which a product can be used by a specific user for a specific 
goal in a specific context or environment, and provides an effective, efficient, and 
satisfying experience [18].”  Usability evaluation is a method for identifying specific 
product usability and involves collecting qualitative and quantitative data [19].  The 
clinical effectiveness of diabetes app use is defined as improvement in glycemic control.   
 
2. Materials and methods 
2.1 Search strategy 
The MEDLINE database did not add the subject heading “mobile application” until 2014.  
To capture publications from before this date, a broad keyword strategy was employed to 
supplement the subject heading strategy.  The subject heading "diabetes mellitus" and the 
keyword diabet* were used for the concept of diabetes.  For the concept of mobile 
applications, subject headings (mobile applications, computers, handheld, and cell 
phones) as well as keywords (mobile, application*, app, apps, mHealth, smartphone*, 
iPhone*, iPad*, android*, handheld computer*, tablet*, and cell* phone*) were 
used.  For the concept of diabetes management, subject heading (self-care) and keywords 
(self-manage*, self-care, and self-monitor*) were used.  The search strings for the three 
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 concepts were combined to retrieve the final search set, and limits for English language 
and 2011-2017 were applied.  These searches were executed in MEDLINE, EMBASE, 
COMPENDEX (Engineering Village) and IEEE XPLORE (Institute of Electrical and 
Electronic Engineering Database).  A manual search for additional publications checked 
the references of prior reviews and included articles.    
 
2.2 Selection of studies  
To be included as a usability study, the app had to be designed for adults with T2D and 
offer two or more app functions, and the article had to report at least one quantitative 
usability outcome.  To be included as a clinical effectiveness study, the article had to 
meet four criteria: (1) the mobile app had to be multi-functional, (2) the study design had 
to be either a randomized controlled trial (RCT), quasi-experimental design, or pre-test 
and post-test, (3) the study population had to consist of adults with T2D, and (4) the study 
had to record at least one glycemic outcome of HbA1c or BG level change.  Studies 
pertaining to type 1 diabetes (T1D) were excluded because some patients with T1D use a 
different technology such as an insulin pump with a built-in BG sensor and an 
accompanying app.  Also, excluded from this review were app interventions studies that 
had a singular app function for text messaging, data upload, phone or video calls, 
education, and access to electronic health records.  App interventions of data upload and 
text messaging have been previously reviewed extensively.  
 
2.3 Study quality assessment 
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 To evaluate the methodology quality, the Cochrane tool was modified for the assessment 
of bias in usability studies [20].  A study was rated as high, low, or unknown potential 
bias.  This evaluation examined how the diabetes app or mHealth system was selected 
and tested.  It also considered whether testing order had randomized sequencing if more 
than one product was tested.  Performance bias checks if the evaluators had systematic 
differences in their ratings.  For example, a patient’s rating may differ from a caregiver’s 
rating.  Detection bias checks whether the usability outcomes are measured in reliable 
and consistent ways over time and across the different products being tested.  Attrition 
refers to whether all the apps were the same version at the different time points of the 
study period (e.g. they did not have a software update or become unavailable in the app 
store).  Assessment for selection bias did not apply to four studies when one group of 
participants performed all usability testing [21-24].  The domain area for usability 
assessment was wide ranging.  To standardize comparison of all usability findings, we 
used a percentage rating by dividing a raw usability score by the maximum possible 
usability score (e.g., usability percentage of 60% is obtained by dividing a score of three 
with its possible maximum score of five).     
Downs and Black checklist was used to assess the quality of clinical effectiveness 
studies because it accounts for randomized and not randomized study designs [25].  
Studies received scores based on 27 items for five biases: (1) reporting, (2) external 
validity, (3) internal validity, (4) confounding factors, and (5) statistical power.  Internal 
validity included measurement bias, performance bias, and attrition.  The maximum 
methodological quality score was modified from 32 to 28, because a dichotomous rating 
was used instead of a 5-point scale to be consistent with other systematic reviews [26].  
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 This modification was necessary because this review contained pilot studies for which a 
power analysis was not suitable.  Studies with a score below 14 were rated as having low 
methodological quality [25].  
 
3. Results 
The search identified 1189 articles:  269 were from MEDLINE, 204 from OVID in 
process, 388 from EMBASE, 161 from COMPENDEX, and 167 from IEEE XPLORE.  
A manual search of four additional articles came from reference lists.  After removing 
duplicates, the first author screened 953 articles (see PRISMA flow chart in Figure 1), 
and excluded 865 articles. Twenty articles were included: seven unique usability studies 
from eight publications [21-24,27-30] and unique clinical effectiveness studies from 12 
publications [31-42].  
 
3.1 Usability overview  
Table 1 summarizes the characteristics of the usability studies - evaluator type, app 
domain, and rating scale.  These studies used diverse methods: heuristic (user friendly 
principle) evaluation [30], patient satisfaction surveys [21,28], “think aloud” video 
recording when performing the required tasks of operation [22,23], screen interactions 
tracked by eye movement [24], and usability inspection [27,29].  Usability evaluators 
included experts [27,29,30], patients [21-24], and caregivers [24].  Types of experts were 
also diverse.  For example, some were medical students supervised by diabetologists 
[27].  Others were mobile device experts, informaticists, nurses, and community health 
workers [29,30].  Reviewed studies also applied assorted theoretical frameworks.  These 
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 frameworks included Shneiderman’s Object-Action Interface Model [43], the 
International Organization for Standardization [18], Framework Analysis [44], and 
Nielsen’s Ten Heuristics [45].  The domain for usability assessment was wide-ranging 
due to the varied theoretical frameworks [21-23,28-30].  
 
3.2 Usability outcomes 
 Diabetes app usability ratings ranged from poor (38%) to average (80%) across the seven 
studies, with specific usability weaknesses found (Table 1).  Usability experts and T2D 
patients indicated manual data entry restricted usability [28,29].  Patients took more time 
and made more errors than expected when exporting and correcting BG values [23].  
They also encountered difficulty in system navigation whenever tasks required multiple 
steps [22,23].  Identified usability problems were mainly product design flaws (e.g., 
screen layout, system capability of reliability, and general characteristics) [21,27-29].  
Usability experts reported design flaws that violated heuristic design principles [29,30].  
This reflected that a mismatch existed between technology design and the real-world 
experience of patients living with T2D.  
 
3.3 Usability study limitations  
Limitations of the usability studies varied.  For most studies, app product selection was 
limited to one app [24] or one mHealth system [21-24,28,30].  This limitation may 
impact the ability to generalize the findings.  In some studies, recruited patients 
participated in prior mHealth studies; so they may have used another app which could 
have influenced their rating [22,23].  One study recruited caregivers who have roles and 
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 perspectives that differed from those of patients [24].  Another potential performance bias 
involved the influence of the app testing order on the evaluators.  None of the usability 
testing had randomized testing order [27,29].  An app tested second or subsequent order 
may receive better score because the evaluators became more familiar with testing.  
Study reports lacked details of the mobile devices used [27,29,30].  No study in this 
review included statistical analysis of confounders such as current history of technology 
uses and patient motivation to control diabetes.  
 
3.4 Clinical effectiveness overview 
Clinical effectiveness studies were diverse with respect to design, setting, intervention 
type, and study follow up (Table 2).   The included studies were randomized clinical 
trials with two arms [34,35,41], three arms [36] or four arms [31], as well as one group 
pre- and post-test design studies [39,40,42,46].  Study settings included primary care, 
community, and university hospital clinics.  The majority of studies took place outside 
the United States: Canada [40], Norway [33,36,37], Finland [35], the United Kingdom 
[34], South Korea [39,42], and Japan [41].  Only two studies occurred in the US 
[31,32,38].  Most studies used diabetes apps in combination with other intervention 
components such as website, decision support, health provider feedback, or personal 
health record.  Only one study reported a theoretical basis (Information-Motivation-
Behavioral Skills Model) for the app intervention [35].  Of the remaining six studies, two 
studies applied the theoretical framework for an education class [36,37] and disease 
management counseling [38].  Duration of app use ranged from 2 to 12 months.  The 
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 majority of the studies reported duration of app use as six months or less (n=6) [33,34,39-
42]. 
 
3.5 Clinical outcomes 
Diabetes app use in all studies decreased HbA1c, ranging 0.15% to 1.9% from baseline.  
However, the reductions were only statistically significant in four studies where the app 
design provided the greatest interactive features – HbA1c reduction of 0.4% to 1.9% 
[31,35,41,42].  Three studies of these studies used between groups comparison 
[31,35,41].  Glycemic changes are difficult to pinpoint because some of the studies had 
concomitant effects with other intervention components such as a website.  Most studies 
used a diabetes app in conjunction with a website, healthcare provider feedback, or 
Bluetooth-enabled devices such as glucometers and blood pressure monitors (Table 2).  
All studies concluded glycemic improvement with diabetes app use.   Of the studies that 
showed statistically significant HbA1c reductions, instant app messages came from an 
algorithm database website [31,42], a primary care provider [31], or a dietician [41] 
(Table 3).  The apps provided feedback messages [31,34,34,39,42] and alert reminders 
[35,39-41].  This functionality adapts for real time data which is helpful for tailoring 
healthy behaviors.  In one study, the app analyzed a meal photo for its carb content to be 
reviewed by a dietician, who then text messages of diet improvement to patients [41].  
 
3.6 Clinical effectiveness study limitations 
The use of diabetes apps in combination with other interventions posed a risk of 
confounding.  Only two of the ten studies reported a power analysis [31,37].  Eight out of 
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 the ten studies did not use any form of blinding [34-37,39-42].  Five studies did not report 
intervention adherence rates [31,33-35,39].  Most studies neglected to report the name of 
the diabetes app and the study device (e.g., smartphone and tablet).  Only four studies 
reported specific diabetes app names [33,36-39].  One diabetes app called Few Touch 
appeared in two studies [33,36,37].  Five out of the ten studies reported the app’s 
operating system [34,36-40].  Study phone devices included Nokia, HTC Windows, 
Tungsten E2, Samsung, and Blackberry. 
 
4. Discussion 
4.1 Interpretation of usability findings 
This review identified diabetes app usability limitations like those noted in prior reviews.  
Many diabetes apps have few functions targeting diabetes self-management [46].  The 
four most common app functions were documentation of diet and medication, weight 
management, and data export [46].  Problem solving strategies for diabetes self-
management were less common [47].  Diabetes apps can provide longitudinal analytics of 
time sensitive BG and carb intake data.  This way patients can improve problem solving 
in self-management by identifying their trends of elevated BG readings and plan when to 
improve self-management behaviors (e.g. following a low carb diet) [48].  Unfortunately, 
many diabetes apps’ analytic features do not meet standards of health literacy.  Only one-
third of apps displayed clear images to facilitate learning and understanding of diabetes 
numbers [49].  Without the right literacy level and user-friendly app features and 
functions, it is difficult for patients to use diabetes apps [50].  Other than intuitive design, 
diabetes app usability may depend on patient factors such as age or sex.  Patients who 
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 were under age 55 took less time in adapting the use of diabetes management software 
app and its accompanied website [23]. 
 
4.2 Interpretation of clinical effectiveness findings  
The use of diabetes apps was associated with improved glycemic control.  However, the 
app use was usually part of multi-component interventions, so it was not always possible 
to distinguish the individual effect.  Most studies used a combination of a diabetes app 
plus other product (e.g., Bluetooth-enabled glucometer and decision support).  Greater 
HbA1c reductions were observed among patients with poor glycemic status of HbA1c 
above 9% [31].  This may influence higher patient motivation to adopt positive behavior 
changes since the primary care providers recruited these patients to enroll in the study.  
Real-time feedback appeared to be the most beneficial app feature.  This may be because 
it enables patients to respond to a specific BG value or carb intake in a timely way.  
Interactive feedback between diabetes apps and patients involved automatic message 
from an app algorithm such as “You have met your target of blood glucose reading five 
times this week” [31], a text message from a dietician who reviewed data and customized 
a meal plan [41], or an alert message whenever a BG reading is out-of-range 
[35,40,41,46].  Diabetes apps with less interactive features had less effect on HbA1c 
reductions (Table 3) [36-38].  Furthermore, diabetes app usability could be limited by the 
number of available app functions to support diabetes self-management behaviors 
recommended by the Association of American Diabetes Educator (AADE7TM) that 
advocate healthy eating, being active, monitoring BG, taking medication, problem 
solving, reducing health risk, and healthy coping.  Many iOS diabetes apps targeted two 
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 out of seven self-management behaviors: BG monitoring and medication use [47].  
Diabetes apps designs need to be more user-friendly for patients and have enough app 
functions that support self-management behaviors. 
 
4.3 Theory and clinical application 
Without health behavior theory guiding diabetes app design, diabetes apps may be 
perceived by patients as not being helpful in promoting positive behaviors.  A recent 
review of health apps showed that most health apps are not consistently grounded in a 
theoretical basis since their designs were mostly information input or output functions 
[51].  Of all the clinical effectiveness studies covered in this review, only one out of nine 
studies (11%) reported the use of a health behavior theory [35], even though it has been 
shown that patient motivation is a strong factor in diabetes management [52,53].  
According to the Self-determination theory (SDT) of motivation, inner motivation 
(personal endorsement of health behaviors) facilitates long-term behavior change, but it 
requires support for three behavior needs: (1) Competence - gaining confidence and skill 
in diabetes self-management such as testing and understanding BG values, (2) Autonomy 
to choose from safe management choices that are personalized or individualized for them, 
and (3) Relatedness or connectivity, which usually means ongoing and supportive 
communication and positive relationship with healthcare providers [54].   
Diabetes apps, then, need to offer patients motivational support to be effective 
aids in self-management.  One way to do this would be to create an easy-to-understand 
BG pattern report that supports patient motivation by teaching which BG values are in-
range and out-of-range.  Another way diabetes apps can help motivate patients to manage 
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 diabetes is to offer a visual report that shows them which days of the week and which 
meals require their focus for improvement.  This would support autonomy and 
personalize specific behavior changes to control diabetes.  Another app function 
important for patient motivation is to promote healthcare provider connectivity by 
sharing health data and reports via email.  Such function would support ongoing 
communication between patients and their healthcare providers, which has been shown to 
improve diabetes management and clinical outcomes [55].  Future studies are needed to 
identify and assess what specific diabetes app features and functions can help promote 
usability and patient motivation for self-management.   
 
4.4 Ethical considerations 
Data privacy and security pose significant ethical and potentially legal challenge to 
making diabetes app use common.  No federal legal protection exists around the 
disclosure of app data to third parties [56].  In addition, the Health Insurance Portability 
and Accountability Act (HIPAA) does not prohibit app companies from sharing sensitive 
health information [57].  According to a 2014 review, 81 percent of Android diabetes 
apps did not provide privacy policies [57], and whatever privacy protection exists can be 
negligible since the data is shared with a third party such as Google [57].  Clinicians must 
take precautions when recommending diabetes apps to patients, then, and specifically 
warn patients to review the privacy policy to determine what health information can be 
shared and with whom.  
 
4.5 Research implications 
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 Future studies need to (1) rigorously focus on how to improve diabetes app design so that 
it supports patient motivation for self-management, (2) provide a methodologically sound 
rationale for the selection of a diabetes app and its related mHealth tools, and (3) assess 
the evidence of the usability and adoption of diabetes app use among diverse population.  
For more specific evidence of diabetes app clinical effectiveness, future studies should 
include: randomized controlled trials using larger sample sizes, effective recruitment 
strategy, and appropriate sampling of intended users.  Monitoring adherence (app use 
frequency) is critical to determining an optimal usage rate required to have clinically 
meaningful significance.  Future studies of diabetes apps also need to incorporate 
individual patient factors of behavior and technology experiences.  Most studies in this 
review did not report important health behavior factors that influence diabetes self-
management such as patient motivation, health literacy, and health numeracy.  Research 
has shown that motivational support from healthcare providers was associated with an 
increase in the use of mHealth tools [55].  Most studies in this review did not report 
patient background in technology experience such as comfort level in using mobile 
technology and the length of smartphone ownership.  Patients reported that low 
technology literacy was a barrier for the use of well-known apps such as Glucose Buddy 
and MyFitnessPal [58].  Statistical analysis should take account of these important patient 
characteristics.  
 
5. Conclusion  
Diabetes apps have great potential to support diabetes self-management.  However, this 
potential is limited since diabetes apps are often not intuitive to use and did not always 
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 have health behavior theory applied in their design and development.  Health behavior 
theory can provide a guiding basis for mHealth intervention designs.  Future research 
should focus on the following questions: What evidence exists to show mHealth 
interventions are most user-friendly and supportive of self-management?  Are diabetes 
apps combined with Bluetooth enabled devices, decision support, and remote provider 
messaging system, the most effective combinations or are other combinations equally or 
more effective?  Future studies also need to examine whether certain patient 
characteristics are more likely to result in initiating and sustaining the use of diabetes 
apps.  Randomized controlled trials that incorporate large sample sizes to detect short-
term effects and long term effects will add knowledge of diabetes mHealth interventions.  
Patient characteristics such as motivation, behavior needs related to motivation, 
technology experience, and app use adherence rate need to be assessed for their effect on 
patient outcomes.  Ethical considerations for the risk of data privacy also need to be 
carefully addressed.  
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 Figure 1 – PRISMA Flow chart of study literature search. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* A total of 7 unique usability studies (one publication was an extension of prior publication) and 
10 unique clinical effectiveness studies (two publications were each an extension of prior 
publication). 
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 2 =SMS text only 
 8 = education/EHR/PHR. 
17= case/ qualitative study 
 4 = commentary article 
18 = no mobile app 
7 = no patients with T2D 
6 = no glycemic outcome 
6 = no usability outcome 
 
 
Studies included in 
quantitative synthesis  
(n = 20)  
Usability studies  
(n = 8)* 
Clinical effect studies  
(n = 12)*   
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 Table 1 – Summary of included usability studies. 
Author Method 
Evaluator  
Theoretical framework 
Tech. platform 
 
App domain/  
Rating scale 
 
Usability outcome examples 
(rating, % of possible maximum)  
Potential bias 
Demidowich  
et al. (2012)  
Usability inspection  
2 medical students  
4 Android apps  
 
6 areas 
Rating 1-5 
Overall usability: 11.3 out of 30 (38%)  
Usability per app function: 3 (60%)  
  
(?) Selection  
(?) Detection 
(+) Other bias 
Alanzi et al. 
(2014) & 
(2016) 
Usability survey  
32 patients  
Shneiderman 
 
1 app/ mHealth  5 areas of QUIS 
Rating 1-9 
 
Overall reaction: Ease of use (6.3, 70%),  
Screen factor: Layout helpful (6.03, 67%)   
Terminology and System Information:  
Clarity (6.09, 67%) 
Learning factor: Error (6.12, 68%), 
System Capabilities: Reliability (5.97, 66%) 
(?) PERF 
(+) Other bias 
Arnhold et al. 
(2014)  
Usability inspection  
3 usability experts   
ISO, Nielsen, Sarodnick, and 
Brau   
66 apps Androids  
and iOS  
 
 
4 areas 
Rating 1-5  
 
Overall usability (3.3, 66%) 
Comprehensibility overall (4, 80%) 
Presentation overall (3.5, 70%) 
General characteristics (2.8, 56%) 
Analysis function reduced usability by 0.21 
(?) Selection 
(?) Detection 
 
Georgsson al. 
(2016a) 
Think aloud, interview, and 
usability survey 
10 patients  
Framework Analysis 
1 SMS-based 
 
UPT: 2 areas, 5  
categories, 21 
subcategories 
Severity 1-4 
19 problems reported 
Severity of medium to serious (2.47, 62%) 
Most frequent problem: multi-steps task,  
interaction, navigation and functionality 
(+) PERF 
(+) Other bias 
Georgsson et 
al. (2016b) 
Observation and survey 
10 patients 
ISO  
1 “Care4Life”  
SMS 
 
7 areas  
SUS:10 items  
Error  
Time  
SUS for satisfaction: 80.5, good  
Task failure and longest: correcting and  
exporting BG values 
 
(+) PERF 
(+) Other bias 
Georgsson et 
al. (2016c) 
Heuristic evaluation,  
3 experts from various area 
Nielsen’s Ten Heuristics 
1 mHealth plus 
SMS 
 
7 areas  
Severity 0-4 
 
Usability problem: n= 129 
Heuristic violation: n= 274 
Severity catastrophic: (12/129, 9.3%)   
Average severity: moderate (2.8, 70%) 
(?) Selection  
(?) Detection 
(+) Other bias 
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Tulu et al. 
(2016) 
Screen reaction: eye  
movement tracking 
5 patients 
1 Android app  
 
3 areas 
Time  
Longest task time: physical activity  
 
(+) PERF 
(+) Other bias 
Note:  
(+) for high risk, (-) for low risk, (n/a) not applicable, (?) for unknown potential bias in the study.  
Abbreviations: App, application; BG, blood glucose; b/t, between; ISO, International Organization for Standardization; PERF, performance; QUIS, questionnaire 
for user interaction satisfaction; SMS, short message service; SUS, System Usability Scale; Tech., technology; UPT, Usability Problem Taxonomy.  
 38 
 Table 2 – Summary of included clinical effectiveness studies.   
Author Design 
 
Number Intervention 
Components 
F/U 
mos
.  
Baseline 
HbA1c (%), 
FBG  
Follow up HbA1c %/ 
Fasting BG at Follow up  
Methodology 
Quality 
Scoreb 
Quinn et  
al. (2011) & 
(2014) 
4 arm cluster RCT 
 
Secondary analysis  
stratified for 
age  
26 
clinics, 
163 
patients 
App  
Website  
Decision Support 
PCP review  
PHR 
12  9.2 
9.3 
9.3 
9.9 
 
Usual care (n=56, 9 clinics): 8.5  
App only (n=23, 4 clinics): 7.7, p=0.027* 
App + WEB (n=22, 6 clincs): 7.9, p=0.40 
App + WEB + decision support (n=62, 7 
clinics): 7.9, p=0.001*  
 
21 
Chomutare et al. 
(2013)  
1 group pre-post 7 App 
Social forum 
3  6.8 6.79, p=NR (not significant) 
 
12d 
Nagrebetsky et al. 
(2013)  
2 arm RCT at  
 
17 App 
Bluetooth sync 
Glucometer 
Paper manual for  
drug titration 
6  8.2  
8.0 
Usual care: NR,  
Treatment group: 7.2, p=0.35a 
 
13d 
Orsama et al. 
(2013) 
2 arm RCT  48 
 
App 
Website  
Decision support 
PHR 
Research nurse  
10  7.1 
6.86 
Usual care: 7.1 
Treatment group: 6.46, p=0.022a* 
 
20 
Holmen et al. 
(2014), 
Torbjørnsen et al. 
(2014)  
3 arm RCT  
 
151 Diary app 
Bluetooth sync  
Glucometer 
Counseling staff 
4  
 
 
12  
8.3 
8.1 
8.2 
8.4 
8.1 
8.2 
Usual care (n=50): 8.0 
App only (n=51): 7.8 
App + counseling (n=50): 7.8, p =0.65 
Usual care (n=41): 8.2 
App only (n=39): 7.8 
App + counseling (n=40):8.0, p =0.57 
18c 
Forjuoh et al. 
(2014) 
4 arm RCT  
 
376 App 
Glucometer 
BP monitor  
6 weeks education  
12  9.2 
9.3 
9.4 
9.2 
Usual care (n=95): 8.5 
App only (n=81): 8.6 
Education only (n=101): 8.3 
App + education (n=99): 8.1 
21c 
Kim et al. (2014) 1 group pre-post,  
 
35 App 
Glucometer 
BP monitor 
3  7.7 7.5, p=0.077 
 
16 
 39 
 
Read (2014)  1 group pre-post  25 App 
Glucometer  
Bluetooth sync 
BP monitor 
Pedometer 
2  
 
6.0 5.88, p=NR (not significant)  13cd 
Waki et al. (2014) 2 arm RCT  
 
54 App  
Website  
Bluetooth sync  
Glucometer 
BP monitor 
Scale 
Pedometer 
Dietitian review 
3  7.0  
7.1 
127.4 (FBG) 
140.2 (FBG) 
Usual care: 7.1 
Treatment group: 6.7, p=0.015* 
Usual care FBG: 144.3 
Treatment group FBG:134.7, p=0.019* 
 
15c 
Kim et al. (2016) 1 group pre-post,  
 
29 App 
Glucometer 
Website 
Provider review 
3  7.7 
140.9 (FBG) 
7.1, p<0.0001* 
FBG:120.1, p=0.013* 
15 
 
Note:  
Abbreviations: App, application; HbA1c, hemoglobin A1c; CI, confidence interval; F/U, follow-up; FBG, fasting blood glucose; NR, not reported; PCP, primary 
care provider; PHR, personal health record; WEB, website. 
P values are reflective of between group comparison (RCTs), or pre-post comparison (quasi-experimental trials) 
*Statistically significant difference in HbA1c or fasting blood glucose reduction compared to usual care. 
aAdjusted for baseline HbA1c. 
bThis methodology quality score is based on Down’s and Black’s checklist (Downs & Black, 1998).  The score can range from 0- 28. 
cStudies reported adherence rate.  
dMethodology quality scoring less than 14 reflects below less than average quality.  
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 Table 3 – Clinical improvement and associated app functions and features. 
Author App Name/ 
Study device  
OS 
HbA1c% 
Reduction 
App Functions  Interactive App 
Features 
Quinn et al. 
(2011) 
 
NR 
 
1.2 -1.9* Documentation and monitoring:  
BG, carbohydrate intake, 
medication, and other diabetes 
data 
Receiver for message 
Education 
Real time message  
based on 
data 
Chomutare 
et al. (2013) 
 
Few Touch/  
NR 
NR 
0.18 Documentation and monitoring:  
BG, diet, physical activity, and 
medication 
Social media chat 
User controlled data sharing 
Exchange 
information  
in social forum 
electronically 
 
Nagrebetsky 
et al. (2013) 
 
NR/ 
Nokia 
Android 
0.6 BG upload and monitoring 
Website decision support 
algorithm 
Real time BG 
feedback  
Orsama et 
al. (2013) 
“Monica”/  
NR 
NR 
0.4* Documentation and monitoring:  
BG, BP, and weight 
 
Feedback message  
Alert reminder 
Holmen et 
al. (2014) 
Torbjørnsen  
et al. (2014)  
Few Touch/  
HTC 
Windows 
Android 
0.15-0.41 Documentation and monitoring: 
BG, diet, physical activity, and 
medication 
Personal goal setting 
Education 
NR 
Furjuoh et 
al. (2014) 
 
Diabetes 
Pilot/ 
Tungsten E2, 
Palm OS 
0.7 -1.1 Documentation and monitoring: 
BG, diet, physical activity, and 
medication 
NR 
Kim et al. 
(2014) 
 
Smartcare/ 
Samsung 
Android 
0.2 Documentation: 
BG and BP 
Weekly BG and BP 
feedback from  
healthcare staff  
Read (2014) 
 
NR/ 
NR 
Blackberry  
0.14 Documentation: 
BG, BP, physical activity, and 
Wt 
 
Alert reminder 
Waki et al. 
(2014) 
 
NR 
 
0.4* Data transmission and monitoring: 
BG, diet, activity, BP, and Wt 
Interpretation of BG data 
Patient voice/text dietary intake 
Meal photo evaluated by dietician 
BG alert to 
providers  
Dietician feedback  
Kim et al. 
(2016) 
 
NR/ 
NR 
Android 
 
0.6* Documentation and monitoring: 
BG upload, diet, medication, 
and physical activity 
Insulin dose  
Social network 
Exercise and education video 
Real time BG 
feedback  
  
Note:  
Abbreviation: App, mobile application; BG, blood glucose; BP, blood pressure; NR, not reported; OS, 
Operating system; PHR, personal health record; Wt, weight.   
*Statistically significant difference in clinical improvement compared to usual care. 
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 SYNOPSIS 
OBJECTIVE – More than 1,100 diabetes apps are available, but are infrequently used. 
Guided by Self-Determination Theory on motivation, this study assessed the usability of 
diabetes apps and whether usability was associated with patient characteristics and 
psychological needs for competence, autonomy, and connectivity. 
RESEARCH DESIGN AND METHODS – Using a crossover randomized design, 92 
adults with type 1 or 2 diabetes tested two Android apps (mySugr and OnTrack) for tasks 
including data entry, blood glucose reports, and data sharing. Multivariable linear 
regression models examined associations between patient characteristics, psychological 
needs, and user satisfaction and user performance (task time, success, and accuracy).    
RESULTS – User satisfaction was independent of patient characteristics except for 
education but associated with psychological needs (P < 0.05). Higher user satisfaction 
was observed for patients with less education and those reported more competence, 
autonomy, or connectivity with a healthcare provider (P < 0.05). User performance was 
associated with age, sex, education, and diabetes duration. Older patients required more 
time and had less successful task completion. Men needed more time and technical 
support than women. Having high school education or less and a diabetes duration 10+ 
years were associated with lower task accuracy (P < 0.01).   
CONCLUSIONS – Diabetes app usability was associated with psychological needs that 
are important for motivation. To enhance patient motivation to use diabetes apps for self-
management, clinicians should consider addressing patient’s competence, autonomy, and 
connectivity. Older male users and those with less education and greater diabetes 
duration may benefit from patient-centered app training and ongoing technical support.  
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 Patients with diabetes may benefit from self-management interventions to prevent 
diabetes-related complications including stroke and vision loss. Poor diabetes 
management is associated with greater healthcare expenditures, 2.3 times higher than 
those without diabetes (Ozieh et al., 2015). Adhering to medical nutritional therapy, 
following a diabetes diet, and determining what to eat on a regular basis are the most 
challenging for many patients with diabetes (American Diabetes Association, 2016b). In 
23% of cases, poor adherence was associated with uncontrolled hemoglobin A1c 
(HbA1c) (American Diabetes Association, 2016a). Using a diabetes app through a 
smartphone to track blood glucose (BG) and diet shows promise to improve diabetes self-
management adherence (Padhye & Wang, 2015). Small trials have shown that using a 
diabetes app can improve glycemic control with a 0.4%–1.9 % reduction in HbA1c levels 
(Orsama et al., 2013; Quinn et al., 2011; Waki et al., 2014). However, diabetes app use is 
low possibly due to design problems and limited usability (Research2Guidance, 2014). 
According to the International Organization for Standardization 9241-11, usability refers 
to how well a specific person uses a product to achieve goals of effectiveness, efficiency, 
and satisfaction in the desired context (Barum, 2011). Hence, diabetes app usability is the 
degree to which an intended user is satisfied with using the app and uses it efficiently and 
effectively to accomplish tasks such as tracking of BG readings.  
 Patient characteristics may influence the usability experience, but few studies 
have examined usability differences based on individual patient characteristics (Alanzi, 
Istepanian, & Philip, 2014; Georgsson & Staggers, 2016b; Tulu, Strong, Agu, Wang, & 
Pedersen, 2016). Age and sex appear to influence the app experience. For example, 
patients aged 56 years and older have reported less satisfaction with using diabetes apps 
 44 
 (Conway, Campbell, Forbes, Cunningham, & Wake, 2015),  and women make more 
errors compared to men in completing tasks such as submitting BG measurements 
(Georgsson & Staggers, 2016b). Other background characteristics, such as technology 
experience and confidence, influence patients’ ability to use diabetes apps. One study 
showed that popular apps such as Glucose Buddy and MyFitnessPal did not match patient 
knowledge and ability, and patients reported that app designs were too complicated 
(Peng, Yuan, & Holtz, 2016). Many health apps mainly provide information input and 
output only, and most do not apply health behavior theory in their design (Riley et al., 
2011), which may be important for a positive experience and long-term app use. Prior 
usability studies also did not assess the quality of diabetes apps based on health behavior 
theories. Assessing app usability and its relationship with patient characteristics and 
health behavior theoretical constructs will fill critical knowledge gaps related to user-
centered design and best practices in promoting diabetes self-management.  
The purpose of this study was to test two top-rated diabetes apps and examine the 
association of usability with patient characteristics and psychological needs important for 
motivation and behavioral change. Aim 1 was to determine the relationships between 
patient characteristics (e.g., age, sex, education, technology use, diabetes history, and 
motivation) and diabetes app usability. We hypothesized that patient characteristics will 
predict user satisfaction and user performance in task time, success, and accuracy. Aim 2 
was to determine the relationships between psychological needs important for motivation 
and app usability. We hypothesized that user satisfaction will be associated with 
psychological needs for competence, autonomy, and healthcare provider connectivity, 
theoretical constructs from Self-Determination Theory.    
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RESEARCH DESIGN AND METHODS  
Theoretical Framework 
This study used Self-Determination Theory (SDT) by Deci and Ryan (2000), a theory of 
motivation, as the framework to understand patient perspectives on app usability. 
Motivation to change is enhanced when patients experience satisfaction for three inherent 
psychological needs: competence, autonomy, and relatedness (Ryan & Deci, 2000). 
Intrinsic motivation is self-initiated when one personally endorses the importance of 
healthy behaviors, while extrinsic motivation is external endorsement for which one acts 
to get an external award, avoid punishment, or to comply with social pressure (R. Ryan et 
al., 2008). When patients recognize the personal benefit of using an app, they are more 
motivated to use it. Figure 1 outlines the influence of patient characteristics on 
psychological needs and product needs that subsequently contribute to user-centered 
design and app use. Competence refers to patient confidence to manage their diabetes by 
keeping their BG in target range (G. Williams et al., 1998). Apps can address the need for 
competence by displaying a summary report of out-of-range BG readings that will in turn 
help patients learn diabetes numeracy (understanding of BG numbers). Autonomy refers 
to patient empowerment to have a menu of options to change behaviors (R. Ryan et al., 
2008). Diabetes apps can address the need for autonomy by providing BG reports and 
carbohydrate (carb) intake patterns by meal. Patients can visualize which meals require 
better carb control and create a personalized behavior action plan. Relatedness is “the 
need to care and be cared for” (Deci & Ryan, 1985). Patients are more likely to adopt 
behaviors when they feel supported and connected with people they trust such as a 
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 healthcare provider (R. Ryan et al., 2008). Apps can assist healthcare provider 
connectivity by providing communication support with a healthcare provider and data 
sharing through email functionality. 
 
Study Design and Participant Eligibility 
This study used a randomized crossover design to test two Android apps (OnTrack and 
mySugr) listed as “the Best Diabetes Apps 2016” by Healthline (health forum). The 
Android platform was selected because it has the greatest number of users (52.7%) in the 
market (Lella, 2016). Because age is a potential confounder in usability testing (Bangor, 
Kortum, & Miller, 2008), we created two age-based strata: adults age ≥ 56 years and 
adults < 56 years. Using a computer software program, a statistician randomly assigned 
an app testing order of AB or BA within each age strata sealed in an opaque envelope for 
each patient. The primary usability outcome was user satisfaction measured by the 
System Usability Scale (SUS) (Brooke, Jordan, Thomas, Weerdmeester, & McClelland, 
1996). Secondary outcomes assessed user performance including efficiency (task time) 
and effectiveness (task success and task accuracy). The University of Minnesota 
Institutional Review Board approved the study, and all participants signed an informed 
consent document prior to app testing. Participants received a $50 honorarium at the end 
of each study session. 
From July 26, 2017, to November 30, 2017, we conducted in-person app testing 
with participants who responded to flyers posted at community or veteran clinics, support 
groups, universities, and community bulletins, as well as online postings on Craigslist 
and Facebook. A total of 110 participants (57% of 193 respondents) were enrolled and 92 
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 participants completed the study. Participants met all inclusion criteria: (1) age 18 or 
older, (2) type 1 or 2 diabetes, (3) insulin therapy for at least 6 months, (4) Android 
smartphone use for at least 6 months, (5) English proficiency, (6) adequate vision to read 
email or text messages on their current smartphone, and (7) smartphone use proficiency. 
Individuals were excluded who used OnTrack or mySugr or any diabetes app in the past 6 
months.  
 
Procedures 
Individual study sessions were held in a private room located in a public library or 
community center mutually agreed upon. The sessions lasted on average 2 hours, with a 
range of 1–3.5 hours. App training included watching YouTube videos posted by the app 
developers. Participants practiced using the app on a study phone, a Samsung 5S, based 
on a task checklist that included seven functions: (1) enter a carbohydrate (carb) intake, 
(2) enter an exercise activity, (3) enter an insulin dose, (4) enter a BG reading, (5) locate 
a BG report for days of the week, (6) locate a BG report for each meal, and (7) email a 
BG report. Participants tested the two apps following a checklist with a different task 
order and data units compared to the practice session.  The SUS questionaire was 
completed at the end of each app test. A 30-minute break took place between the first and 
second app test. During the break, participants completed the background survey and 
were given an opportunity to eat a light snack and use the restroom. App training and 
testing was conducted by the principal investigator following the study protocol that 
included a standardized tip sheet used to provide technical support requested by the 
participants. Another research staff member checked fidelity from the audio recording of 
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 the study sessions. Field notes and app preference comments were recorded by the 
principal investigator. 
 
Measurements 
User satisfaction (primary outcome) was determined by the SUS, a10-item questionnaire 
administered immediately after each app test (Brooke et al., 1996). The SUS is widely 
used in technology usability evaluation with a reliability coefficient alpha of 0.91 
(Bangor et al., 2008) and a loading factor > 0.3 for construct validity (Lewis & Sauro, 
2009). Scores > 70 show acceptable usability with scores ≥ 85 considered excellent 
usability. Scores between 50 and 69 reflect marginally acceptable usability, and scores ≤ 
50 are unacceptable usability (Bangor, Staff, Kortum, Miller, & Staff, 2009). Secondary 
outcomes were user performance evaluation: (1) app efficiency measured by task time, 
and (2) app effectiveness measured by task success and accuracy. Task time is the total 
task completion time per app. Task success is the degree to which a user independently 
completed required tasks (Nielsen, 2001). Each app task success was rated from 0% to 
100%, accounting for the degree of independent use. The rating is zero when the app is 
missing one of the seven testing functions or the patient received more than 50% of the 
tips listed in the standardized tip sheet. The user success rate was computed by compiling 
the different ratings for each testing function and then averaging them. Accuracy rating is 
whether the patient performed tasks correctly (e.g., correct insulin dose). Its score was an 
average accuracy of all tested app tasks.  
 Patient characteristics were self-reported using a background survey of 32 items 
that included demographics (age, sex, race/ethnicity, and education), smartphone brand, 
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 technology use, diabetes factors (types, HbA1c, duration, insulin use, BG testing, and 
prescribed BG testing), plus an established motivation scale, the Treatment Self-
Regulation Questionnaire (TSRQ), assessing patients’ reasons for engaging in diabetes 
self-management behaviors with 8 items for intrinsic motivation and 11 items for 
extrinsic motivation rated on a seven-point Likert scale (G. Williams et al., 1998). Both 
types of motivation scores were calculated by averaging the response ratings, which 
ranged from 1 (not true at all) to 7 (very true). Overall motivation was assessed by the 
Relative Autonomy Index (RAI), calculated by subtracting the intrinsic motivation score 
from the extrinsic motivation score. Positive scores indicate higher relative autonomy 
from intrinsic motivation, whereas negative scores indicate lower relative autonomy from 
more extrinsic motivation. TSRQ has been validated across settings and for other health 
behaviors with an internal consistency alpha coefficient > 0.73 in a prior study (Levesque 
et al., 2007) and 0.82 in this study.  
  Competence was measured by the Perceived Competence Scale (PCS), which 
assesses competence in diabetes self-management rating, which ranged from 1 (not true 
at all) to 7 (very true) on a 7-point Likert scale with four items and scored by averaging 
the responses (G. C. Williams, Ryan, & Deci, 1999). Its internal consistency alpha 
coefficient was > 0.80 in a prior study (G. Williams et al., 1998) and 0.88 in this study. 
Taking an interest in learning is a subcomponent of autonomy (R Ryan & Deci, 2006). 
Autonomy in diabetes management was measured by four items designed by the 
investigator and validated with expert testing that estimated patient interest in personal 
trends for BG readings and carb intake. Responses are on a 5-point Likert scale rating 
from 1 (strongly disagree) to 5 (strongly agree) and scored by averaging the responses. Its 
 50 
 alpha coefficient of 0.74 was acceptable. Healthcare provider connectivity was rated by 
the Health Care Climate Questionnaire (HCCQ), assessing the degree to which primary 
healthcare providers offer autonomous support in diabetes management (G. Williams, 
McGregor, Zeldman, Freedman, & Deci, 2004). The score is based on an average 
response to six items on a 7-point Likert scale rating from 1 (strongly disagree) to 7 
(strongly agree). Its reliability alpha coefficient was 0.82 in a prior study (G. Williams et 
al., 2004) and 0.94 in this study. 
 
Statistical Analysis  
The sample size calculation for a linear mixed effect multiple regression model (n = 84) 
was based on 13 predictor variables, R2 correlation matrix of 0.2, and 0.05 alpha. To 
account for 10% attrition, the target sample size for this study was 92.  All analyses were 
performed using R statistical software version 3.4.1 released June 30, 2017 (Team, 2017). 
The only missing data was a HbA1c level from one participant. Residual plots showed no 
evidence of heteroskedasticity. Paired t tests of mySugr and OnTrack usability scores 
showed significant differences (P < 0.05), which called for all analyses to be adjusted for 
app group and testing order with an interaction term. Analyses of t tests and Chi-square 
assessed differences between two age strata and sex groups using a 0.05 significance 
level. 
 For Aim 1 to determine patient characteristics’ association with app usability, a 
linear mixed effect multiple regression model of ANOVA analyzed both random effect 
(app group) and fixed effect (repeated app testing). The full model was run separately for 
each usability outcome and checked for P < 0.05 statistical significance. A full model 
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 included 15 predictors of patient characteristics with smartphone brand and education 
collapsed into dichotomous variables. For Aim 2 to assess the relationship between 
psychological needs and app usability, the model for Aim 1 was used by adding a 
psychological need predictor (e.g., competence) while adjusting patient characteristics 
covariates (key demographics, technology factors, diabetes history, and motivation), 
testing order, app group, and interaction term between testing order and app group. We 
assessed the individual mediation effect of task time, success, and accuracy on user 
satisfaction to explain all or part of the relationship between the psychological need and 
user satisfaction (Tingley, Yamamoto, Hirose, Keele, & Imai, 2014). For any significant 
finding (P < 0.05), multiple analysis correction with Bonferroni was used with a cutoff of 
0.0008333 (derived from 0.05 divided by 60, because there were 15 hypotheses tested 
with four models assessing the effects of patient characteristics on SUS, time, success, 
and accuracy). Meanwhile a cutoff of 0.000781 (derived from 0.05 was divided by 64) 
was used for four models assessing psychological needs’ effects. 
 
RESULTS  
Sample Recruitment and Characteristics 
Diverse recruitment sites yielded 92 participants living in urban and suburban Minnesota 
locations: 46 were recruited from Facebook (50%), eight from patient referrals (9%), 
seven from a community clinic (8%), six from a university (6.5%), six from public 
housing (6.5%), five from Craigslist (5%), four from a veteran clinic (4%), three from 
diabetes support groups (3%), and seven from miscellaneous sites such as a state fair, 
church, and library (8%). Participant characteristics are presented in Table 1. More than 
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 half of participants were women, nearly half used Samsung brand phones, and 70% had 
type 2 diabetes. The mean age was 54 years (range 19–79), and the mean HbA1c was 
8.2% (range 5–14) or 66 mmol/mol (range 31–130).  
 
App Usability 
Participants rated the two top-rated apps as having marginally acceptable usability (SUS 
scores between 50 and 69). OnTrack received an SUS score of 68 that is considered a 
“D” grade usability, e.g., scores between 60 and 69. Meanwhile, mySugr received a SUS 
score of 55 that is a “F” grade usability, e.g., scores less than 60. Task time (efficiency) 
was significantly better for OnTrack compared mySugr (mean 6.6 vs 7.5 minutes, 
respectively, P < 0.001). OnTrack had higher user performance effectiveness scores than 
mySugr with 84% vs. 80% task success (P = 0.03) and 74% vs. 63% task accuracy (P < 
0.001).  
 
Patient Characteristics and App Usability Outcomes 
Demographics, technology use, diabetes factors, or motivation of the patients did not 
predict user satisfaction assessed by the SUS for tested apps (Table 2). However, patient 
characteristics of age, sex, and education predicted secondary outcomes of task time and 
success rate. Adults over age 56 years took an extra 2.2 minutes [95% CI 1.1–3.2] for 
task time, had lower task success [95% CI 3.5–14.3], and made more task errors [4.2–
16.4] compared with adults age 18–55 years. On average, for every 10 years of age, adult 
patients spent 0.8 minute longer (P < 0.05) and the task success rate decreased by 4.6% 
(P < 0.01). Men were less proficient compared with women. They took an extra 1.7 
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 minutes (P < 0.05) and were 6.9% less successful (P < 0.05). Participants who had 
education beyond high school had less user satisfaction by 6.4 (P < 0.41) and greater 
success by 10.5% compared to those who did not. There was a trend for a significant 
difference in higher accuracy for current Samsung smartphone users by 7.3% (P = 0.054).  
Although neither type 1 or 2 diabetes predicted task time or success, other 
diabetes characteristics played a significant role in user performance. Diabetes duration 
had a negative effect on accuracy (P = 0.023). The longer duration of diabetes, the less 
accurate participants were in using diabetes apps. A 10-year increase in diabetes duration 
was associated with an 8.5% drop in task accuracy, whereas, the duration of insulin use 
tended to be associated with an increase of 7.1% in accuracy (P = 0.058). Glycemic 
control of HbA1c level demonstrated no association between user satisfaction and user 
performance. Other factors of self-reported BG testing frequency, prescribed BG testing 
frequency, and motivation for diabetes care were not associated with usability outcomes.  
 
Psychological Needs and App Usability Outcomes 
Psychological needs were significantly associated with user satisfaction (P < 0.05), but 
they were not associated with user performance. This supports our study hypothesis that 
patient ratings of psychological needs of competence, autonomy, and healthcare provider 
connectivity are related to user satisfaction in diabetes apps. Patients who rated 
competence in diabetes care, perceived satisfaction with diabetes apps. A one-unit 
increase in diabetes competence score was associated with an increase of the SUS score 
by 3.1 points (P < 0.05). Similarly, patients who reported greater autonomy and interest 
in learning their personal BG and carb patterns perceived greater user satisfaction with 
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 the diabetes apps (P < 0.01). A one-unit increase in the autonomy score regarding patient 
interest to learn personal BG and carb patterns was associated with an increase of the 
SUS score by 5.9 points (P < 0.01). Patients who rated a higher connectivity with 
healthcare providers expressed higher user satisfaction. A one-unit increase of 
connectivity score was associated with increased SUS score of 2.5 points (P < 0.05). The 
association between user satisfaction and psychological needs was mediated by task time, 
success, and accuracy in a small proportion (0.5%–19.7%), which was not statistically 
significant. 
 
CONCLUSIONS	
To our knowledge, this study is the first to report how patient characteristics and 
psychological needs are related to diabetes app usability. A strength of our approach was 
the relatively large and diverse study population (n = 92) for usability testing, because 
most mHealth usability evaluations have fewer than 30 participants and limited 
recruitment sites. Our study population had a mix of residents from urban and suburban 
counties including African Americans and Native Americans. Our findings indicate that 
psychological needs and education are important factors in app usability, whereas, patient 
characteristics are important for user performance or the ability to use an app efficiently, 
successfully, and accurately.  
 Diabetes app usability, as assessed by user satisfaction (SUS), was not associated 
with age, sex, diabetes profiles, technology factors, or motivation. Psychological needs 
were associated with user satisfaction. Competence in diabetes care was associated with 
greater user satisfaction. In our study, patients reported a desire to use the app to increase 
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 their competence and preferred the convenience of being able to track data on the go. A 
middle-aged patient noted that “this would work for me since I always have my phone.” 
Apps offering an analysis report make it “easy to see the BG was out of range,” 
according to another patient.  These findings are consistent with prior research in which 
patients report liking educational information and goal setting in apps to help them plan 
self-management activities (Peng et al., 2016). 
 Autonomy in diabetes care as assessed by interest in personal patterns correlated 
with greater usability satisfaction. This finding is consistent with prior research, which 
found that diabetes app use helped patients set realistic goals and see choices to modify 
their behaviors (Peng et al., 2016). Patients are also interested in a customized diabetes 
care plan within an app to help them control diabetes and learn to change their eating 
habits (Sarkar et al., 2016). According to one 62-year-old patient, a diabetes app can 
show “the last three months … how food influenced my BG, eating habits, and time 
frame in the schedule fluctuation.”  
 Addressing patient desire or need for connectivity with a healthcare provider is 
important for patient engagement in a mHealth intervention. Patients who were well-
connected and received autonomous support from their healthcare provider rated higher 
user satisfaction with diabetes apps. Patients were more motivated to engage in diabetes 
care and use mHealth tools when they perceived their healthcare providers to be 
autonomous supportive (Graffigna et al., 2016). Diabetes apps can facilitate data sharing 
and patient–provider communication. As one 58-year-old patient indicated. “[I do] not 
rely on my memory to tell my doc how I have been doing, … I can just show her my 
phone.” Clinicians can view data trends and patterns in analysis reports emailed to them 
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 or view them on patients’ smartphones during clinic visits. Clinicians can pinpoint areas 
for behavior changes based on real-time data.  
Patient characteristics correlated with patients’ ability to use an app. There were 
user performance differences based on patient characteristics. Age, sex, education, and 
diabetes duration were related to task time, success, and accuracy when controlled for 
covariates (e.g., education, diabetes types, HbA1c, BG testing, and motivation). A10-year 
age difference was associated with slower task performance of 0.8 minutes and lower 
task success by 4.6%. However, when taking into account the covariates, age was not 
associated with accuracy. This is somewhat surprising as the typical expectation is that 
younger users are more accurate with technology use. This may be related to the design 
of this study, which provided as much technical support and time as desired. In contrast 
to prior studies, women outperformed men in time efficiency and task success. This result 
held when accounting for other participant factors and might be explained by the greater 
amount of time that women spend on smartphones and apps than men. For example, one 
study that tracked 75,000 people using the most popular websites and apps found that 
women spend more time than men on smartphones (49% vs. 39%) (Burmaster, 2016). 
Women also use social media apps (e.g., Facebook) more often than men (83% vs. 75%) 
(Greenwood, Perrin, & Duggan, 2016). We ran a separate full model adjusted for 
Facebook recruitment and the statistical significance did not change, thus we concluded 
that Facebook recruitment factor did not affect results. Another important user 
performance factor was education. Education beyond high school only correlated with 
user success performance but not user efficiency or accuracy. This potentially means that 
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 when participants with high school education or less are provided with technical support, 
they can learn to use an app as efficiently and accurately as those with more education. 
Diabetes duration was significantly related to user accuracy performance. A 10-
year diabetes history was associated with a decrease of 8.5% in user accuracy. This might 
be because of diabetes complications such as peripheral neuropathy and retinopathy. 
Diabetes peripheral neuropathy rate increases by twofold for those with diabetes for 
longer than 10 years (Jaiswal et al., 2017). Diabetes retinopathy prevalence at 10 years 
diabetes duration is 60% (Fong et al., 2004). Finger nerve pain may make it hard and 
painful to tap correct app icons. Icons and prints in a small smartphone screen would be 
hard to read for those with vision complications. In this study, the majority of participants 
had uncontrolled diabetes with elevated mean HbA1c level of 8.2% (66 mmol/mol). A 
HbA1c level of < 7.5% (58 mmol/mol) for adults older than age 65 years (Care, 2016) 
and ≤ 7% (53 mmol/mol) for adults under age 65 without a history of hypoglycemia is 
considered well-controlled diabetes (American Diabetes Association, 2016b). However, 
glycemic status was not related to app usability, nor was BG monitoring frequency or 
motivation in diabetes care.  
Several limitations for this study give direction for future app research. Two 
diabetes apps were tested in a single study session. Although results are applicable for a 
short-term app experience, user satisfaction may be different when patients use diabetes 
apps long-term in their home environments. Future research should include long-term 
follow-up, record app adherence rate, and assess factors affecting whether or not long-
term app use will be sustained. Different proportion of White versus non-White 
participants were recruited through sites such as public housing and a community clinic 
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 classified as a federal qualified health center. This heterogeneity in race breakdown by 
recruitment made it challenging to distinguish between race effect and recruitment effect. 
Therefore, we did not include race/ethnicity as a covariate in the final model.  
There may be significant covariates that we did not measure such as 
socioeconomic status (e.g., income), types of medical insurance, diabetes complications, 
and obesity status that could have influenced the results. However, our study used 
multiple recruitment sites through both in-person and online advertisement. We obtained 
participants with different backgrounds in education level, insulin use types (insulin 
pump users on private insurance as wells those on public insurance program on injection 
therapy), and both private and public housing facilities. Covariates such as education and 
smartphone model included in the analysis may count as proxy for socioeconomic status. 
We also used a multiple variable model taking into account common patient 
characteristics in demographics and diabetes history. Our study excluded adolescents 
living with diabetes as well as family caregivers. Future studies should consider 
recruiting minority patients, adolescents, and caregivers. We did not include laboratory-
based usability measures. The addition of usability tests that include video recording 
screen reaction, counting keystrokes, and tracking eye movements may further identify 
usability problems and barriers to diabetes app use.  
Our study provides new insights into the theoretical basis of health behavior in 
diabetes app usability. Application of the Self-Determination Theory in diabetes app 
design proved to be important for bridging the gap between patient needs and technology 
experience. Psychological needs of competence, autonomy, and connectivity with a 
healthcare provider (motivational constructs), were associated with app user satisfaction. 
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 These findings suggest that clinicians should address these psychological needs when 
recommending the use of a diabetes app.  For example, clinicians could address 
competence by providing education on pattern recognition and teaching patients how to 
plan lifestyle modifications (e.g., lowering carb intake). Clinicians could customize a care 
plan and target range for BG to address autonomy need so that patients can set up a 
parameter in their apps and have the app analyze BG data accordingly. Clinicians could 
also offer autonomous support and receive home-monitored data via email to promote 
patient motivation to use app long-term.  
App vendors could better support data sharing and data aggregation (e.g. BG 
analysis reports import into medical record) to make information more accessible to 
clinicians. The length of diabetes duration greater than 10 years should alert clinicians to 
screen for diabetes complications that may affect user accuracy. In addition, user-
centered apps are desired by patients, regardless of their background. App designs and 
features should match appropriate user age and ability such as having high school 
education or less, technology learning, health literacy, and health numeracy. Patient-
centered app training and ongoing technical support would improve usability experience 
for older male users and those with less education and greater diabetes duration. Other 
app considerations include enabling voice-over commands and wireless data uploads to 
improve accuracy by eliminating manual data entry.  
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 Table 1–Sample characteristics and psychological needs 
Characteristics/ psychological needs (n = 92) 
Age, years (SD) 54 (13) 
Men, n (%) 38 (41) 
Race, n (%)  
White 57 (62) 
Black/African American 23 (25) 
Native American 10 (11) 
Asians 2 (2) 
Highest completed education, n (%)  
Elementary 4 (4) 
High school or equivalent 27 (29) 
Community/technical school 31 (34) 
Bachelor’s degree 19 (21) 
Graduate degree 11 (12) 
Device brand, n (%)  
Samsung 44 (48) 
LG 19 (20) 
iPhone 8 (9) 
ZTE 7 (8) 
Motorola 6 (6) 
Other   8 (9) 
Smartphone comfort level, n (%)  
Very uncomfortable 23 (25) 
Neither  12 (13) 
Comfortable 33 (36) 
Very comfortable 24 (26) 
Diabetes types, n (%)  
Type 1 28 (30) 
Type 2 64 (70) 
HbA1c % (ranges 5–14) 8.2* (1.5) 
Diabetes duration (years) 17 (11) 
Insulin duration (years)  12 (12) 
Insulin use types, n (%)  
Insulin pump 14 (15) 
Long- and short-acting injection 46 (50) 
Long-acting injection 28 (30) 
Short-acting injection  2 (2) 
None (stopped use)  2 (2) 
BG testing prescribed per day 3.8 (1.8) 
BG testing per day 6.2 (1.4) 
Daily or less, n (%)  19 (21) 
2 times a day, n (%) 34 (37) 
4 times a day, n (%) 21 (23) 
> 4 times a day, n (%) 18 (19) 
Overall motivation**  2.16 (1.3) 
Intrinsic motivation  5.43 (0.9) 
Extrinsic motivation  3.26 (1.2) 
Competence 5.38 (1.1) 
Autonomy  3.92 (0.6) 
Connectivity with healthcare provider  6.05 (1.2) 
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 Data are mean (SD) unless otherwise indicated. Abbreviation: BG, blood glucose and 
HbA1c, hemoglobin a1c. *66 mmol/mol, **Also known as the self-determination index 
obtained from intrinsic motivation score minus extrinsic motivation score. 
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 Table 2–Adjusted associations between patient characteristics and app usability  
Predictors  
Satisfaction  
(SUS) 
Efficiency  
(min) 
Success  
(%) 
Accuracy  
(%) 
Characteristics, effect (P) Model 1 Model 2 Model 3 Model 4 
Age per 10 years −0.5 (0.683) 0.8 (0.016) * −4.6 (0.003) ** −2.5 (0.149) 
Men vs. women 0.1 (0.965) 1.7 (0.012) * −6.9 (0.038) * −0.1 (0.988) 
> HS vs. ≤ HS¶  −6.4 (0.041) * −1.2 (0.096) 10.5 (0.003) ** 0.3 (0.942) 
Samsung vs. not Samsung 1.5 (0.603) −0.8 (0.240) 5.3 (0.112) 7.3 (0.054) 
Smartphone comfort 0.6 (0.508) −0.1 (0.694) 0.6 (0.605) −0.3 (0.793) 
Diabetes type 2 vs. type 1  −5.5 (0.224) 1.6 (0.121) −4.7 (0.355) −7.4 (0.199) 
Diabetes duration per 10-year 3.6 (0.224) 0.5 (0.483) −0.1 (0.982) −8.5 (0.023) * 
Insulin duration per 10-year −1.3 (0.660) 0.6 (0.372) −3.1 (0.356) 7.1 (0.058) 
HbA1c 0.4 (0.674) −0.2 (0.322) 1.8 (0.071) 0.7 (0.505) 
BG testing per day −0.4 (0.779) 0.2 (0.398) −1.7 (0.238) −1.0 (0.671) 
BG testing prescribed per day −0.2 (0.840) −0.2 (0.445) 0.9 (0.441) −1.2 (0.456) 
Motivation (TRSQ) −0.4 (0.71) −0.03 (0.881) 0.7 (0.562) −0.1 (0.937) 
Testing order −3.9 (0.276) −1.2 (0.079) 11.2 (0.001) ** 3.6 (0.407) 
App group 8.4 (0.019) * −1.3 (0.048) ** 9.8 (0.006) ** 11.1 (0.010) * 
Interaction order and app 8.3 (0.131) 0.9 (0.468) −11.3 (0.071) −0.5 (0.942) 
Adjusted R2¶¶ 0.14 0.35 0.31 0.17 
N = 184 observations from randomized 92 patients. No significant P met the cutoff of 
0.0008333 with Bonferroni multiple comparison. ¶Completed highest education greater 
than high school compared with those who’s highest completed education was high 
school or less, those who did not; *P < 0.05; **P < 0.01; ¶¶obtained from linear regression 
model analysis without repeated measures.  
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 Table 3–Adjusted associations between psychological needs and app usability  
 
Satisfaction  
(SUS) 
Efficiency  
(min) 
Success  
(%) 
Accuracy  
(%) 
Competence  Model 1A Model 2A Model 3A Model 4A 
Adjusted effect (P) 3.1 (0.023) * 0.2 (0.616) −0.1 (0.936) −2.9 (0.101) 
Adjusted R2¶ 0.16 0.35 0.31 0.18 
     
Autonomy  Model 1B Model 2B Model 3B Model 4B 
Adjusted effect (P) 5.9 (0.006) ** −0.8 (0.105) 4.9 (0.049) * 1.2 (0.677) 
Adjusted R2¶ 0.17 0.37 0.33 0.17 
     
Connectivity  Model 1C Model 2C Model 3C Model 4C 
Adjusted effect (P) 2.5 (0.029) * 0.2 (0.479) −0.02 (0.862) −0.01 (0.953) 
Adjusted R2¶ 0.16 0.35 0.31 0.17 
N = 184 observations from randomized 92 patients, adjusted all models with 15 
covariates listed in model 1 from Table 2, which included: age, sex, education, use of 
Samsung, smartphone comfort, diabetes types, diabetes duration, insulin duration, 
hemoglobin a1c, blood glucose testing per day, blood glucose testing prescribed per day, 
motivation, testing order, app group, and interaction term between order and app. No 
significant P met the cutoff of 0.000781 with Bonferroni multiple comparison. *P < 0.05; 
** P < 0.01; and ¶obtained from linear regression model analysis without repeated 
measures. 
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 Supplemental Table 4–Diabetes app usability outcomes 
Usability  
Overall 
(N = 184) 
mySugr 
(n = 92) 
OnTrack 
(n = 92) 
d [95%CI] 
(n = 92) P* 
Practice time, minutes      
Mean (SD) 19 (8) 22 (9) 16 (6) 5.6 [4.0, 7.2] < 0.001 
Median (IQR) 17 (9) 20 (8) 14 (8) 5 (7)  
Satisfaction       
Mean (SD) 62 (18) 55 (18) 68 (15) 12.7 [8.2, 17.2] < 0.001 
Median (IQR) 65 (23) 56 (25) 70 (15) -15 (25)  
Efficiency, minutes      
Mean (SD) 7.0 (3.8) 7.5 (3.8) 6.6 (3.7) 0.8 [0.3, 1.3] < 0.001 
Median (IQR) 6.0 (4.5) 6.4 (4.5) 5.6 (4.0) 0.7 (2.3)  
Success, %      
Mean (SD) 82 (19) 80 (20) 84 (18) -3.9 [0.3, 7.5] < 0.05 
Median (IQR) 92 (33) 83 (33) 92 (25) 0 (16.7)  
Accuracy, %      
Mean (SD) 68 ± 21 63 (22) 74 ± 20 -11.0 [6.0, 16] < 0.001 
Median (IQR) 67 (33) 67 (33) 67 (17) -16.6 (33.3)  
N = 184 observations from randomized 92 patients who tested two apps in randomized 
order *Obtained from paired t test comparing two apps, mySugr and OnTrack.  
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 Chapter 4: Synthesis 
 The rise in popularity of smartphones creates a wide reach for mobile health 
intervention. The majority of Americans now own a cellphone (95%) and 77% do use a 
smartphone (PewResearchCenter, 2018). The health app market boomed with sales 
projected to reach $31 billion by 2020 (Research2Guidance, 2014). Because of the high 
percentage of adults aged 65 years who have diabetes (25.2%) (Centers for Disease 
Control and Prevention, 2017) and a substantial number of older adults aged 65+ (46%) 
who use smartphones (Anderson & Perrin, 2017), diabetes apps are high priority for app 
developers (Comstock, 2016). According to the mHealth Economic 2017 study, 68% of 
mobile health app developers and publishers believe that diabetes continues to be the 
therapy field with the best market potential for digital health solutions (Nikolova, 2017). 
Nevertheless, despite the availability of more than  1,100 diabetes apps, their usage is so 
low that less than 2% of diabetes apps have a significant number of downloads 
(Research2Guidance, 2014). Diabetes apps also fall off the market so quickly that 60 
Android apps became unavailable within 6 months (Blenner et al., 2016).  
There is much to be learned about diabetes apps and why they are not being used. 
This dissertation aimed to understand diabetes app usability and its fit for patient users 
based on individual characteristics and behavior needs posited by the Self-Determination 
Theory on motivation. This was accomplished in two phases: (1) a systematic review of 
diabetes app usability testing and clinical effectiveness, and (2) patient testing of diabetes 
app usability. Low diabetes app usage may be explained by evidence of suboptimal user 
satisfaction and major usability problems. Clinical studies with interactive app 
components demonstrated app clinical efficacy to improve diabetes control. New findings 
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 from patient app testing revealed the importance of health behavior theory application in 
app usability. Patient user satisfaction with diabetes apps is driven by the satisfaction of 
inherent psychological needs that are important for motivation.  
 
Prior Usability Evidence 
 Diabetes app research is an interdisciplinary science with a wide range of testing 
methods and perspective, which makes it an interesting science. It is a new field with 
limited numbers of published quantitative usability studies and clinical studies specific to 
diabetes apps. The systematic review on diabetes apps yielded only seven usability 
studies in a comprehensive search of the literature in computer science, engineering, 
informatics, medicine, and nursing. We examined findings from heuristic (user-friendly 
principle) evaluation, satisfaction surveys, and “think aloud” video recording when 
performing the required tasks of operation, screen interactions tracked by eye movement, 
tracking user performance, and usability inspection. The systematic review synthesized 
the evidence of app usability in testing mode as well as clinical setting mode. In testing 
mode, patients as well as clinical and informatics experts rated low satisfaction with 
diabetes app usability. In the clinical setting mode, the evidence of diabetes apps to assist 
self-management and improve glycemic control was limited. Diabetes app effectiveness 
to lower HgA1c level ranged from 0.15% (a minimal change) to 1.9% (a significant 
change that is clinically meaningful > 0.5%). Most studies found no statistically 
significant change in diabetes outcomes. Although four studies did report significant 
findings, they used an app intervention component that included interactive features for 
real-time feedback in the forms of:  1) automatic messages from an app algorithm that 
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 monitored whether a reading was abnormal; 2) text messages from clinicians; 3) reminder 
alerts; and 4) app-initiated phone calls in response to a critical need for a clinic visit. 
 Evidence of diabetes app usability in testing and clinical setting modes suggested 
the need for health behavior theory applications to guide app development and research 
toward a user-centered tool that is interactive and enables patients to engage in health 
behavior change. Testing app usability in randomized trials and having patients evaluate 
app tasks specific for self-management are important to understand why a patient will or 
will not use an mHealth tool, such as a diabetes app.   
 
New Evidence: Adult Patients Testing Diabetes App Usability 
Given the daily demands of managing their diabetes, adult patients desire an 
efficient and effective app to promote and reinforce positive health behavior change. 
Applying health behavior theory in app design to increase diabetes app usability is the 
first step to better understand the patient’s perspective of good usability. This dissertation 
applied the Self-Determination Theory on human motivation to select app testing 
functions and to understand patient perspectives on using diabetes apps. This dissertation 
tested the usability of app functions to record health data as well as those functions meant 
to target patient competence, autonomy, and connection with a healthcare provider for 
diabetes care. A total of 92 adults living with diabetes type 1 or 2 participated in a 
randomized crossover trial to evaluate the usability of two top-rated Android diabetes 
apps (mySugr and OnTrack) listed as “The Best Diabetes Apps in 2016” by Healthline 
(health forum). Multivariable linear regression models examined the effects of individual 
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 patient characteristics and psychological needs on user satisfaction (primary outcome) 
and user performance (secondary outcomes: task time, success, and accuracy). 
Application of a health behavior theory such as SDT proved to be a link between 
patients and a mHealth tool. The psychological needs of the patient that are important for 
motivation and behavioral change were associated with diabetes app usability. Patients 
have three inherent needs: competence, autonomy, and connectivity with a healthcare 
provider (relatedness with someone they trust). When patients recognize the personal 
benefit of using diabetes apps to address their psychological needs, they may be more 
motivated to use them. Psychological needs were associated with user satisfaction in 
diabetes apps. Higher user satisfaction was observed for patients who reported 
competence, autonomy, or connectivity with a healthcare provider. To enhance 
motivation to use diabetes apps for self-management, clinicians should consider 
addressing the patient’s competence, autonomy, and connectivity. 
Patient characteristics of age, sex, education, and diabetes duration were 
associated with user performance because they affect the patient’s ability to use diabetes 
apps efficiently, successfully, and accurately. On average, for every 10 years of age, adult 
patients spent 0.8 minutes longer and the task success rate decreased by 4.6%. Our study 
found women were faster and more successful time than men to use apps, contradictory 
to prior study that tested one diabetes mHealth system and its app (Georgsson & 
Staggers, 2016b). A high school education or less and a diabetes duration greater than 10 
years correlated with lower task accuracy. Therefore, app training and ongoing technical 
support should be tailored for older adults, men, and those with less education and 
diabetes duration more than 10 years. 
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Limitations of Prior Evidence of Diabetes App Usability 
The literature review on diabetes app usability was limited by a number of factors, 
including app selection, participant recruitment, performance bias, the lack of 
randomized testing order, and the absence of key technology use and psychological 
confounders (e.g.,	adherence rate and motivation to control diabetes). Usability testing 
with end users such as patients or caregivers mainly used one app product or mHealth 
system that the research team developed. Their findings may be generalizable to features 
offered by that particular study app system. There was product selection bias and 
performance bias related to how participants were selected and the lack of randomized 
testing order. Two studies pooled patients who were registered or participated in a prior 
mHealth study (Georgsson, Staggers, & Weir, 2016; Georgsson & Staggers, 2016a, 
2016b). Experts that tested multiple apps did not randomize their testing order; therefore, 
the second app reviewed may have a biased rating from a carryover learning effect and 
the subsequent app may be rated as a better app (Arnhold et al., 2014; Demidowich, Lu, 
Tamler, & Bloomgarden, 2012). Half the reviewed clinical studies did not report app use 
adherence rate. It is unknown whether the app effect was diminished owing to a drop in 
adherence.  
 
Limitations of Current Study on Diabetes App Usability 
This dissertation study tested two diabetes apps in a one-time session. The results 
are applicable for a short-term experience; user satisfaction may be different for long-
term use. This study included different proportions of White versus non-White 
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 participants from recruitments sites such as a public housing and a community clinic 
classified as a federal qualified health center. This heterogeneity in race breakdown by 
recruitment made it challenging to distinguish between race effect and recruitment effect. 
There may be significant covariates that were not measured, such as socioeconomic 
status (e.g., income), types of medical insurance, diabetes complications, and obesity 
status that could have influenced the results. Another limitation of our study was 
exclusion of adolescent patients and family caregivers. We also did not include 
laboratory-based usability measures (e.g., eye tracking movement) to quantify user 
efforts to perform each required app task. An automatic data upload feature with the 
potential to improve user accuracy was not included in the study, because during the 
pilot, the features were not reliable and its supporting Bluetooth device had to be returned 
to the manufacturer. 
 
Future Directions  
Mobile app research is an exciting new field. Several important improvements in 
study design and app development would advance knowledge in mHealth science. Future 
studies should apply health behavior theory to guide study design, measure patients’ 
psychological needs, and compare behavior changes in response to app use. Future 
research should also include long-term follow-up, measure health literacy and numeracy, 
record overall intervention and app use adherence rates, and assess factors affecting 
whether or not long-term app use will be sustained. Studies should also consider 
recruiting minority patients, adolescents, and caregivers. The additional usability 
evaluation that includes video recording screen reactions, counting keystrokes, and 
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 tracking eye movements may further identify usability problems and barriers to diabetes 
app use. App features of voice-over commands and wireless data uploads should be 
included to determine whether it improves user accuracy performance by eliminating 
manual data entry. 
 
Implications  
Application of the Self-Determination Theory in diabetes app design helped 
explain the gaps in patient adoption of diabetes app technology. Psychological needs of 
competence, autonomy, and connectivity with a healthcare provider were key factors for 
promoting user satisfaction with diabetes apps. Clinicians should consider patients’ 
wishes for diabetes care competence, autonomy, and connectivity with a healthcare 
provider when making referrals to a diabetes app. Clinicians could address competence 
by providing education on pattern recognition and teaching patients how to plan lifestyle 
modifications. Clinicians could customize a care plan with a BG target range to promote 
autonomy so patients can program it in a diabetes app. Clinicians could offer autonomous 
support and review home-monitored data via email to optimize patient motivation to use 
diabetes apps regularly. The length of diabetes duration greater than 10 years should alert 
clinicians to assess whether these patients are good candidates to use an app well in the 
presence of diabetes complications such as neuropathy and retinopathy. 
App vendors or companies could offer app interoperability with electronic health 
record and supporting data aggregation so clinicians can quickly access analysis reports 
from diabetes app during clinic visits or phone encounters with patients. Furthermore, 
user-centered apps are desired by patients, regardless of their background. App designers 
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 and developers should make apps that fit user age and ability, such as the confidence to 
learn new technology, health literacy, and health numeracy. Patient-centered app training 
and ongoing technical support would improve the usability experience for older adults, 
men, and those with less education and greater diabetes duration. A simple design that 
makes completing tasks less complicated may be preferred by some patients. Minority 
populations such as African Americans, Hispanics/Latinos, Native Americans, and 
Asians may benefit from an app design tailored with culturally appropriate language and 
educational content messages.  
 
Summary 
To our knowledge, this is the first large randomized study to evaluate app usability by 
patients guided by a health behavior theory. The application of a health behavior theory 
demonstrated to an important factor that Self-Determination Theory on motivation 
provided the basis for selecting app tasks as well as the guiding framework to understand 
patient motivation to use diabetes apps. Diabetes apps have the potential to promote 
personalized care as part of precision medicine, including addressing the inherent 
psychological needs for patient motivation in diabetes care. Diabetes care competence, 
autonomy, and connectivity with a healthcare provider are the foremost considerations 
for assessing if a patient is ready to use a diabetes app, because user satisfaction is 
associated with these psychological needs. Patient characteristics of age, sex, education, 
and diabetes durations are key patient profiles and should be considered in app design, 
training, and ongoing technical support because they may affect patients’ ability to use 
apps efficiently, successfully, and accurately, initially as well as long term.   
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 Appendix C: mySugr Practice Checklist 
 
Instruction for mySugr 
Task #1: Enter what you ate. 
  apple  
  30 gm   
  BREAKFAST,  
  6 AM,  
  TODAY   
Task #2: Enter exercise 
  Jogging  
  30 min,  
  After lunch  
  1 pm,  
  2 DAYS AGO  
 
Task #3:  Enter medication 
  Lantus insulin 
  10 units  
  6 pm  
  DINNER 
  YESTERDAY    
 
Task #4: Enter blood sugar reading 
  200 mg/dl  
  BREAKFAST  
  7 am  
  TODAY  
 
Task #5: Read a report on WHICH day of the 
week (such as MONDAY) the blood sugar 
readings were not normal. 	
Task #6: NOT AVAILABLE   
 
Task #7: Email a blood sugar report to 
sugrTIPS@gmail.com  
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 Appendix D: OnTrack Practice Checklist 
 
Instruction for OnTrack 
Task #1: Enter what you ate. 
  Apple  
  2 carb choices,  
  BREAKFAST,  
  6 AM,  
  TODAY   
Task #2: Enter exercise 
  Jogging  
  30 min,  
  After lunch,  
  1 pm  
  2 days ago 
Task #3:  Enter medication 
  Lantus insulin 
  10 units,  
  6 pm,  
  Dinner 
  YESTERDAY    
 
Task #4: Enter blood sugar reading 
  200 mg/dl  
  BREAKFAST  
  7 am  
  TODAY  
 
Task #5: NOT AVAILABLE	
Task #6: Read a blood sugar report on WHICH 
MEAL (breakfast, lunch, dinner, or snacks) the 
blood sugar readings were not normal.   
 
Task #7: Email a blood sugar report to 
sugrTIPS@gmail.com  
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 Appendix E: mSugr Test Checklist 
 
MYSUGR 
 
Task #4: Enter blood sugar reading.    
  380 mg/dl   
  DINNER,  
  7:30 PM  
  YESTERDAY    
  STOP -  staff needs to check app 
 
Task #3 - Enter what diabetes drug you took:    
  Lantus insulin 12 units 
  at BEDTIME,  
  10:30 PM  
  YESTERDAY    
  STOP -  staff needs to check app   
 
Task #7: Email a blood sugar report to sugrTIPS@gmail.com  
  STOP -  staff needs to check app  
 
Task #1: Enter what you ate.    
  BREAKFAST 
  6:00 AM  
  TODAY    
  Pizza  
  48 gram   
  STOP -  staff needs to check app 
 
Task #2: Enter what activity or exercise you did.      
  7 AM 
  TODAY 
  Before Breakfast   
  swimming 30 min     
  STOP -  staff needs to check app 
   
Task #6: NOT AVAILABLE  
 
Task #5: Read a report on WHICH day of the week (such as 
MONDAY) the blood sugar readings were not normal.  
  STOP -  staff needs to check app  
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 Appendix F: OnTrack Test Checklist 
 
ONTRACK 
 
Task #1: Enter what you ate.    
  Bagel  
  3 carb choices   
  BREAKFAST  
  8:00 am  
  YESTERDAY 
  STOP -  staff needs to check app 
 
Task #2: Enter what activity or exercise you did.      
  After LUNCH,  
  1 PM    
  TODAY    
  Jogging 30 min    
  STOP -  staff needs to check app 
 
Task #6: Read a blood sugar report on WHICH 
MEAL (breakfast, lunch, dinner, or snacks) the blood sugar 
readings were not normal. 
  STOP -  staff needs to check app 
 
Task #4: Enter blood sugar reading.    
  180 mg/dl   
  DINNER,  
  5:30 PM  
  YESTERDAY    
  STOP -  staff needs to check app 
 
Task #5: NOT AVAILABLE 
   
Task #7: Email a blood sugar report to sugrTIPS@gmail.com 
STOP -  staff needs to check app   
 
Task #3 - Enter what diabetes drug you took:    
  Lantus insulin 8 units,  
  BREAKFAST,  
  8 AM  
  TODAY     
  STOP -  staff needs to check app 
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 Appendix G: Trademark and Copyright 
 
In preparation for the implementation of the ideas described in this dissertation, at my 
request the University has filed an application with the US Patent and Trademark Office 
to register the trademark “SugrTIPS” (derived from “Self-Determined Glucose Roadmap 
TIPS”) in International class 009, electrical and scientific apparatus (for the device –
diabetes app), and International class 044, medical analysis services (for the service). The 
application serial number is # SN 87225550. The application was filed on an “intent to 
use” basis, and a Notice of Allowance was issued August 29, 2017. Once the mark is 
used in commerce, a Statement of Use may be filed and registration will issue. A 
Statement of Use may not be filed later than the date that is thirty-six (36) months from 
the date on which the Notice of Allowance was issued.  
 
Some portion of this dissertation was previously published in Diabetes Research and 
Clinical Practice. As the author of this Elsevier article, I retained the right to reuse it for 
this dissertation, provided it is not published commercially.  
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